Roxburgh et al. in a review looking in to role of the systemic inflammatory response (SIR) in predicting survival for patients with cancer using biochemical or haematological markers recognised hypoalbuminaemia to be significant as an inflammatory marker along with C-reactive protein (CRP), neutrophils and lymphocyte/ platelet ratio [9]. The gene discussed is CRP; the disease is cancer.